Skip to main content

Lichter Jay's Form 4 filing

Janux Therapeutics, Inc. (JANX) · filed Sep 10, 2024

Accession no.
0001415889-24-023153
Filed
Sep 10, 2024, 5:02 PM ET
Trade date
Sep 6-9, 2024
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 8 non-derivative transactions and 4 derivative transactions. Open-market sales total $10.2M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lichter JayCIK 000137635510% Owner
Avalon Ventures XI, L.P.CIK 000165290110% Owner
Avalon BioVentures SPV I, L.P.CIK 000184455010% Owner
Avalon BioVentures I, LPCIK 000187393510% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 6, 2024Common StockSSaleDisposed−108,365$42.00−$4,551,3303,162,851Direct
Sep 6, 2024Common StockSSaleDisposed−20,991$42.00−$881,622612,682Indirect
Sep 6, 2024Common StockSSaleDisposed−110,644$42.00−$4,647,0483,229,374Indirect
Sep 9, 2024Common StockMOption exerciseAcquired+994$17.00+$16,8988,077Direct
Sep 9, 2024Common StockMOption exerciseAcquired+414$10.73+$4,442.228,491Direct
Sep 9, 2024Common StockMOption exerciseAcquired+414$13.22+$5,473.088,905Direct
Sep 9, 2024Common StockMOption exerciseAcquired+277$39.80+$11,024.69,182Direct
Sep 9, 2024Common StockSSaleDisposed−2,182$42.33−$92,364.067,000Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 9, 2024Common StockMOption exerciseDisposed−994$0.00$029,006Direct
Sep 9, 2024Common StockMOption exerciseDisposed−414$0.00$012,086Direct
Sep 9, 2024Common StockMOption exerciseDisposed−414$0.00$012,086Direct
Sep 9, 2024Common StockMOption exerciseDisposed−277$0.00$08,073Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)